Raag Agrawal , Sarah Al-Hiyari , Rupert Hugh-White , Robert Hromas , Yash Patel , Elizabeth A. Williamson , Mohammed F.E. Mootor , Alfredo Gonzalez , Jianmin Fu , Roni Haas , Madison Jordan , Brian L. Wickes , Ghouse Mohammed , Mao Tian , Molly J. Doris , Christian Jobin , Kevin M. Wernke , Yu Pan , Takafumi N. Yamaguchi , Seth B. Herzon , Michael A. Liss
{"title":"高立克次碱对前列腺癌具有依赖性和非依赖性作用","authors":"Raag Agrawal , Sarah Al-Hiyari , Rupert Hugh-White , Robert Hromas , Yash Patel , Elizabeth A. Williamson , Mohammed F.E. Mootor , Alfredo Gonzalez , Jianmin Fu , Roni Haas , Madison Jordan , Brian L. Wickes , Ghouse Mohammed , Mao Tian , Molly J. Doris , Christian Jobin , Kevin M. Wernke , Yu Pan , Takafumi N. Yamaguchi , Seth B. Herzon , Michael A. Liss","doi":"10.1016/j.euo.2024.10.015","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and objective</h3><div>The etiology of prostate cancer (PC) is multifactorial and poorly understood. It has been suggested that colibactin-producing <em>Escherichia coli</em> positive for the pathogenicity island <em>pks</em> (<em>pks</em><sup>+</sup>) initiate cancers via induction of genomic instability. In PC, androgens promote oncogenic translocations. Our aim was to investigate the association of <em>pks</em><sup>+</sup> <em>E. coli</em> with PC diagnosis and molecular architecture, and its relationship with androgens.</div></div><div><h3>Methods</h3><div>We quantified the association of <em>pks</em><sup>+</sup> <em>E. coli</em> with PC diagnosis in a volunteer-sampled 235-person cohort from two institutional practices (UT San Antonio). We then used colibactin 742 and DNA/RNA sequencing to evaluate the effects of colibactin 742, dihydrotestosterone (DHT), and their combination in vitro.</div></div><div><h3>Key findings and limitations</h3><div>Colibactin exposure was positively associated with PC diagnosis (<em>p</em> = 0.04) in our clinical cohort, and significantly increased replication fork stalling and fusions in vitro (<em>p</em> < 0.01). Combined in vitro exposure to colibactin 742 and DHT induced more somatic mutations of all types than exposure to either alone. The combination also elicited kataegis, with a higher density of somatic point mutations. Laboratory analyses were conducted using a single cell line, which limited our ability to fully recapitulate the complexity of PC etiology.</div></div><div><h3>Conclusions and clinical implications</h3><div>Our findings are consistent with synergistic induction of genome instability and kataegis by colibactin 742 and DHT in cell culture. Colibactin-producing <em>pks<sup>+</sup> E. coli</em> may plausibly contribute to PC etiology.</div></div><div><h3>Patient summary</h3><div>We investigated whether a bacterial toxin that is linked to colon cancer can also cause prostate cancer. Our results support this idea by showing a link between the toxin and prostate cancer diagnosis in a large patient population. We also found that this toxin causes genetic dysfunction in prostate cancer cells when combined with testosterone.</div></div>","PeriodicalId":12256,"journal":{"name":"European urology oncology","volume":"8 3","pages":"Pages 716-730"},"PeriodicalIF":8.5000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Colibactin Exerts Androgen-dependent and -independent Effects on Prostate Cancer\",\"authors\":\"Raag Agrawal , Sarah Al-Hiyari , Rupert Hugh-White , Robert Hromas , Yash Patel , Elizabeth A. Williamson , Mohammed F.E. Mootor , Alfredo Gonzalez , Jianmin Fu , Roni Haas , Madison Jordan , Brian L. Wickes , Ghouse Mohammed , Mao Tian , Molly J. Doris , Christian Jobin , Kevin M. Wernke , Yu Pan , Takafumi N. Yamaguchi , Seth B. Herzon , Michael A. Liss\",\"doi\":\"10.1016/j.euo.2024.10.015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background and objective</h3><div>The etiology of prostate cancer (PC) is multifactorial and poorly understood. It has been suggested that colibactin-producing <em>Escherichia coli</em> positive for the pathogenicity island <em>pks</em> (<em>pks</em><sup>+</sup>) initiate cancers via induction of genomic instability. In PC, androgens promote oncogenic translocations. Our aim was to investigate the association of <em>pks</em><sup>+</sup> <em>E. coli</em> with PC diagnosis and molecular architecture, and its relationship with androgens.</div></div><div><h3>Methods</h3><div>We quantified the association of <em>pks</em><sup>+</sup> <em>E. coli</em> with PC diagnosis in a volunteer-sampled 235-person cohort from two institutional practices (UT San Antonio). We then used colibactin 742 and DNA/RNA sequencing to evaluate the effects of colibactin 742, dihydrotestosterone (DHT), and their combination in vitro.</div></div><div><h3>Key findings and limitations</h3><div>Colibactin exposure was positively associated with PC diagnosis (<em>p</em> = 0.04) in our clinical cohort, and significantly increased replication fork stalling and fusions in vitro (<em>p</em> < 0.01). Combined in vitro exposure to colibactin 742 and DHT induced more somatic mutations of all types than exposure to either alone. The combination also elicited kataegis, with a higher density of somatic point mutations. Laboratory analyses were conducted using a single cell line, which limited our ability to fully recapitulate the complexity of PC etiology.</div></div><div><h3>Conclusions and clinical implications</h3><div>Our findings are consistent with synergistic induction of genome instability and kataegis by colibactin 742 and DHT in cell culture. Colibactin-producing <em>pks<sup>+</sup> E. coli</em> may plausibly contribute to PC etiology.</div></div><div><h3>Patient summary</h3><div>We investigated whether a bacterial toxin that is linked to colon cancer can also cause prostate cancer. Our results support this idea by showing a link between the toxin and prostate cancer diagnosis in a large patient population. We also found that this toxin causes genetic dysfunction in prostate cancer cells when combined with testosterone.</div></div>\",\"PeriodicalId\":12256,\"journal\":{\"name\":\"European urology oncology\",\"volume\":\"8 3\",\"pages\":\"Pages 716-730\"},\"PeriodicalIF\":8.5000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European urology oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2588931124002451\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/14 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European urology oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2588931124002451","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/14 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景和目的:前列腺癌(PC)的病因是多因素的,目前尚不清楚。有人认为,致病性岛 pks(pks+)阳性的产大肠杆菌通过诱导基因组不稳定性引发癌症。在 PC 中,雄激素会促进致癌易位。我们的目的是研究 pks+ 大肠杆菌与 PC 诊断和分子结构的关联及其与雄激素的关系:方法:我们从两家机构(UT 圣安东尼奥)的 235 人队列中对 pks+E. coli 与 PC 诊断的相关性进行了量化。然后,我们使用 colibactin 742 和 DNA/RNA 测序来评估 colibactin 742、双氢睾酮 (DHT) 及其组合在体外的影响:在我们的临床队列中,高立克次素暴露与 PC 诊断呈正相关(p = 0.04),并显著增加了体外复制叉停滞和融合(p 结论和临床意义:我们的研究结果表明,在细胞培养过程中,可乐菌素 742 和 DHT 可协同诱导基因组不稳定性和卡他性。患者总结:我们研究了一种与结肠癌有关的细菌毒素是否也会导致前列腺癌。我们的研究结果表明,在大量患者中,该毒素与前列腺癌诊断之间存在联系,从而支持了这一观点。我们还发现,当这种毒素与睾酮结合时,会导致前列腺癌细胞的基因功能紊乱。
Colibactin Exerts Androgen-dependent and -independent Effects on Prostate Cancer
Background and objective
The etiology of prostate cancer (PC) is multifactorial and poorly understood. It has been suggested that colibactin-producing Escherichia coli positive for the pathogenicity island pks (pks+) initiate cancers via induction of genomic instability. In PC, androgens promote oncogenic translocations. Our aim was to investigate the association of pks+E. coli with PC diagnosis and molecular architecture, and its relationship with androgens.
Methods
We quantified the association of pks+E. coli with PC diagnosis in a volunteer-sampled 235-person cohort from two institutional practices (UT San Antonio). We then used colibactin 742 and DNA/RNA sequencing to evaluate the effects of colibactin 742, dihydrotestosterone (DHT), and their combination in vitro.
Key findings and limitations
Colibactin exposure was positively associated with PC diagnosis (p = 0.04) in our clinical cohort, and significantly increased replication fork stalling and fusions in vitro (p < 0.01). Combined in vitro exposure to colibactin 742 and DHT induced more somatic mutations of all types than exposure to either alone. The combination also elicited kataegis, with a higher density of somatic point mutations. Laboratory analyses were conducted using a single cell line, which limited our ability to fully recapitulate the complexity of PC etiology.
Conclusions and clinical implications
Our findings are consistent with synergistic induction of genome instability and kataegis by colibactin 742 and DHT in cell culture. Colibactin-producing pks+ E. coli may plausibly contribute to PC etiology.
Patient summary
We investigated whether a bacterial toxin that is linked to colon cancer can also cause prostate cancer. Our results support this idea by showing a link between the toxin and prostate cancer diagnosis in a large patient population. We also found that this toxin causes genetic dysfunction in prostate cancer cells when combined with testosterone.
期刊介绍:
Journal Name: European Urology Oncology
Affiliation: Official Journal of the European Association of Urology
Focus:
First official publication of the EAU fully devoted to the study of genitourinary malignancies
Aims to deliver high-quality research
Content:
Includes original articles, opinion piece editorials, and invited reviews
Covers clinical, basic, and translational research
Publication Frequency: Six times a year in electronic format